Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.48 |
| ▸ | ARG2 | P78540 | 4/20 | 0.44 |
| ▸ | ARG1 | P05089 | 3/20 | 0.44 |
| ▸ | DDAH1 | O94760 | 2/20 | 0.41 |
| ▸ | OTC | P00480 | 1/20 | 0.41 |
| ▸ | NOS2 | P35228 | 6/20 | 0.40 |
| ▸ | NOS1 | P29475 | 4/20 | 0.40 |
| ▸ | NOS3 | P29474 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7974900 | 1.00 | GSR (0.48) | GSRARG2ARG1DDAH1OTC | |
| Hydrochloric Acid SCHEMBL4581849 | 0.98 | GSR (0.47) | GSRARG2ARG1DDAH1OTC | |
| Hydrochloric Acid SCHEMBL4424849 | 0.98 | GSR (0.47) | GSRARG2ARG1DDAH1OTC | |
| Hydrochloric Acid SCHEMBL7977023 | 0.98 | GSR (0.47) | GSRARG2ARG1DDAH1OTC | |
| Hydrochloric Acid SCHEMBL7974008 | 0.98 | GSR (0.47) | GSRARG2ARG1DDAH1OTC | |
| SCHEMBL1504429 | 0.95 | GSR (0.46) | GSRARG2ARG1DDAH1OTC | |
| SCHEMBL4316097 | 0.95 | GSR (0.46) | GSRARG2ARG1DDAH1OTC | |
| SCHEMBL21067514 | 0.95 | GSR (0.46) | GSRARG2ARG1DDAH1OTC | |
| Hydrochloric Acid SCHEMBL8900288 | 0.93 | GSR (0.44) | GSRARG2ARG1DDAH1OTC | |
| Hydrochloric Acid SCHEMBL4057533 | 0.93 | GSR (0.44) | GSRARG2ARG1DDAH1OTC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3230440-A1 | COMPOSITIONS AND METHODS FOR NEURONAL DIFFERENTIATION OF CELLS | Northern Sydney Local Health District (AU) | 2017-10-18 | — | — | EP | claimed |
| WO-2016090408-A1 | COMPOSITIONS AND METHODS FOR NEURONAL DIFFERENTIATION OF CELLS | NORTHERN SYDNEY LOCAL HEALTH DISTRICT (AU) | 2016-06-16 | — | — | WO | claimed |
| WO-2010037095-A2 | AGENTS AND METHODS FOR THE TREATMENT OF CANCER | NOMETICS (CA) | 2010-04-01 | — | — | WO | claimed |
| EP-1633311-A4 | COMPOSITIONS AND METHODS FOR MODULATING S-NITROSOGLUTATHIONE REDUCTASE | UNIV DUKE (US) | 2009-06-03 | — | — | EP | claimed |
| EP-1534313-A4 | OPHTHALMOLOGIC IRRIGATION SOLUTIONS AND METHOD | OMEROS CORP (US) | 2008-06-25 | — | — | EP | claimed |
| EP-1633311-A2 | COMPOSITIONS AND METHODS FOR MODULATING S-NITROSOGLUTATHIONE REDUCTASE | DUKE UNIVERSITY (US) | 2006-03-15 | — | — | EP | claimed |
| EP-1534313-A2 | OPHTHALMOLOGIC IRRIGATION SOLUTIONS AND METHOD | Omeros Corporation (US) | 2005-06-01 | — | — | EP | claimed |
| WO-2005000229-A2 | COMPOSITIONS AND METHODS FOR MODULATING S-NITROSOGLUTATHIONE REDUCTASE | DUKE UNIVERSITY (US) | 2005-01-06 | — | — | WO | claimed |
| US-20040235751-A1 | Reduction of zinc-induced neurotoxic injury by blockade of nitric oxide synthesis | FREDERICKSON CHRISTOPHER J (US) | 2004-11-25 | — | — | US | claimed |
| WO-2004084827-A2 | REDUCTION OF ZINC-INDUCED NEUROTOXIC INJURY BY BLOCKADE OF NITRIC OXIDE SYNTHESIS | NEUROBIOTEX, INC. (US) | 2004-10-07 | — | — | WO | claimed |
| WO-2004010894-A2 | OPHTHALMOLOGIC IRRIGATION SOLUTIONS AND METHOD | OMEROS CORPORATION (US) | 2004-02-05 | — | — | WO | claimed |
| EP-4709378-A1 | COMPOUNDS FOR NOS-RELATED CANCERS AND METHODS OF USE | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2026-03-18 | — | — | EP | disclosed |
| WO-2024231899-A1 | COMPOUNDS FOR NOS-RELATED CANCERS AND METHODS OF USE | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2024-11-14 | — | — | WO | disclosed |
| EP-4265641-A1 | DEVELOPMENT AND APPLICATION OF COMPLEMENT INHIBITOR | Keymed Biosciences Co.,Ltd. (CN) | 2023-10-25 | — | — | EP | disclosed |
| EP-4213816-A1 | MULTI-TARGETING CELL-DERIVED NANOPARTICLES AS A VERSATILE THERANOSTIC | Fondazione Istituto Italiano di Tecnologia (IT) | 2023-07-26 | — | — | EP | disclosed |
| WO-2000002580-A2 | THERAPIES USING HEMOPROTEINS | DUKE UNIVERSITY MEDICAL CENTER (US) | 2000-01-20 | — | — | WO | disclosed |
| EP-0961835-A1 | METHOD FOR IDENTIFYING SELECTIVE INHIBITORS OF NITRIC OXIDE SYNTHASE | UNIVERSITY COLLEGE LONDON (GB) | 1999-12-08 | — | — | EP | disclosed |
| WO-1998035055-A1 | METHOD FOR IDENTIFYING SELECTIVE INHIBITORS OF NITRIC OXIDE SYNTHASE | UNIVERSITY COLLEGE LONDON (GB) | 1998-08-13 | — | — | WO | disclosed |
| EP-0618898-A1 | AMIDINO DERIVATIVES AND THEIR USE AS NITRIC OXIDE SYNTHASE INHIBITORS | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-10-12 | — | — | EP | disclosed |
| WO-1993013055-A1 | AMIDINO DERIVATIVES AND THEIR USE AS NITRIC OXIDE SYNTHASE INHIBITORS | THE WELLCOME FOUNDATION LIMITED (GB) | 1993-07-08 | — | — | WO | disclosed |